ApoE genotype-specific inhibition of apoptosis

Robert M. DeKroon, Mirta Mihovilovic, Zoe V. Goodger, Jennifer B. Robinette, Patrick M. Sullivan, Ann M. Saunders, Warren J. Strittmatter

Journal of Lipid Research · 2003 · 39 citations · 23 references

DOIFull text

Open access

Concepts

Abstract

Endothelial cell apoptosis can be initiated by withdrawing growth factors or serum, and is inhibited by HDL. Our results show that the total lipoprotein population from apolipoprotein E 4/4 (APOE4/4) sera is less anti-apoptotic than total lipoproteins from other APOE genotypes, as measured by caspase 3/7 activity. Moreover, APOE4/4 VLDL antagonizes the antiapoptotic activity of HDL by a mechanism requiring binding of apoE4 on VLDL particles to an LDL family receptor.This ability of APOE4/4 VLDL to inhibit the antiapoptotic effects of HDL presents a potential mechanism by which the expression of several diseases, including atherosclerosis, is enhanced by the APOE4 genotype. Endothelial cell apoptosis can be initiated by withdrawing growth factors or serum, and is inhibited by HDL. Our results show that the total lipoprotein population from apolipoprotein E 4/4 (APOE4/4) sera is less anti-apoptotic than total lipoproteins from other APOE genotypes, as measured by caspase 3/7 activity. Moreover, APOE4/4 VLDL antagonizes the antiapoptotic activity of HDL by a mechanism requiring binding of apoE4 on VLDL particles to an LDL family receptor. This ability of APOE4/4 VLDL to inhibit the antiapoptotic effects of HDL presents a potential mechanism by which the expression of several diseases, including atherosclerosis, is enhanced by the APOE4 genotype. Endothelial cells undergo apoptotic cell death to including growth and and of which to apoptosis and a of and cell apoptosis to and on and other as and inhibit cell apoptosis and of a apoptosis of cells from and the and to inhibit cell of cell apoptosis by lipoproteins and that HDL apoptosis cells by and that and antiapoptotic activity of HDL. of the family that the which of cell apoptosis by lipoproteins and and a apolipoprotein E lipoprotein and and is of from to and of and the the APOE4 of apoE4 and the LDL family of lipoprotein activity of the E to a the of lipoprotein and the of particles E and binding of lipoproteins to cell E VLDL and apoE4 HDL. and apoE4 VLDL and mechanism of lipoprotein of apolipoprotein on lipoprotein and of and and atherosclerosis, the E lipoprotein and of the LDL family of an of less than lipoprotein activity of the E to a HDL cell and the of APOE the of lipoprotein lipoproteins from sera of APOE inhibit and of cells from and and an of of cell and cells cells to and of of and or the of lipoproteins of lipoprotein of the and the of of sera as to 3/7 activity 3/7 activity measured the by a of is a to a a by and activity by the the of from that and caspase to activity the of lipoproteins to of lipoprotein APOE to or apoE4 apolipoprotein and of and and or APOE4 of the apolipoprotein E the and and from of on a from sera of as and of lipoproteins of by of and to by the of lipoproteins and lipoprotein of the of VLDL a of to a and HDL a and and total lipoproteins a of HDL to of the HDL particles the VLDL and to and a of lipoproteins and antiapoptotic activity of lipoproteins by antiapoptotic activity lipoproteins or on the total lipoproteins and lipoprotein and VLDL as the of the of lipoproteins sera of a APOE genotype. of the of sera to the of the lipoproteins from that sera the lipoprotein and by the of from the a of the lipoprotein to of to a of by the of of measured and the from to of lipoprotein from total lipoprotein to a to of that from and apolipoprotein E 4/4 (APOE4/4) a of lipoprotein to of to the by of cell apoptosis by lipoproteins and by on a an from to a of by and and of and to of the the the activity of ability to cells from apoptosis the caspase 3/7 activity and of of sera from on the lipoprotein to the by and by by by of by and enhanced to the of apoptosis by total lipoproteins is APOE the APOE and by of and by lipoprotein and lipoproteins from from and from and or and the of lipoprotein APOE E and binding of lipoproteins to cell E VLDL and of the apolipoprotein E the and and from of lipoprotein APOE as the of lipoproteins the lipoproteins to the of caspase and lipoproteins from and sera apoptosis lipoproteins from APOE4/4 less apoptosis caspase activity of APOE4/4 and of sera to that of other and antiapoptotic activity APOE of cell apoptosis by lipoproteins and that the ability of lipoproteins to from apoptosis is by including and lipoproteins to of APOE4/4 lipoproteins the ability of lipoproteins to the of from the as the of the other to lipoprotein and antiapoptotic activity. of total lipoprotein ability to from antiapoptotic activity. of and total lipoproteins as antiapoptotic activity. of total lipoprotein from and APOE4/4 of the the ability to from to the antiapoptotic activity of total lipoproteins from and APOE4/4 of antiapoptotic activity of total lipoproteins HDL antiapoptotic activity is on APOE the of total lipoproteins show a the APOE genotypes, the of lipoproteins and from and and and APOE4/4 sera ability to of the antiapoptotic activity the HDL APOE ability of HDL from to apoptosis that of apoptosis by HDL VLDL and lipoproteins from APOE a of the ability of HDL from APOE4/4 to inhibit apoptosis to that of HDL from other APOE the the of the lipoprotein genotypes, from or of lipoprotein on caspase activity of caspase activity by from and APOE4/4 than that or the HDL lipoproteins from APOE and APOE 4/4 sera inhibited caspase to a from the and as VLDL the antiapoptotic activity of VLDL from APOE the antiapoptotic activity of HDL. of of APOE4/4 VLDL to a of APOE4/4 HDL activity of HDL APOE4/4 or VLDL on HDL activity that the of apoptosis by the total lipoproteins APOE4/4 sera is to the ability of APOE4/4 VLDL to the antiapoptotic activity of HDL. the antiapoptotic activity of HDL is APOE of HDL activity. of of VLDL to a of HDL on HDL of caspase activity. VLDL from APOE4/4 from or inhibit the of caspase activity by HDL. as a APOE4/4 HDL and APOE4/4 HDL APOE4/4 other HDL or VLDL of other APOE HDL antiapoptotic VLDL HDL activity by a mechanism requiring the of the apoE4 on the which binding of to the LDL family of cell lipoprotein and including and an of on the ability of APOE4/4 VLDL to inhibit HDL. APOE4/4 VLDL from HDL antiapoptotic on the antiapoptotic activity of HDL that the effects of APOE4/4 VLDL binding of apoE4 to LDL family effects of on APOE4/4 VLDL of HDL activity. of HDL activity by APOE4/4 VLDL on VLDL from or to inhibit HDL activity from of the APOE as of VLDL to HDL activity be to the of of VLDL and the ability of to to the family can to HDL activity. VLDL to inhibit HDL antiapoptotic the LDL family VLDL of HDL activity from a of VLDL particles or a apoE4 the VLDL the the and APOE4/4 VLDL on the of VLDL APOE4/4 VLDL inhibited HDL the of VLDL which inhibit of APOE4/4 and of APOE4/4 and VLDL of HDL antiapoptotic activity on of VLDL the APOE4/4 VLDL lipoproteins show of HDL APOE4/4 and VLDL and a of and APOE4/4 to VLDL is as and VLDL from to on HDL activity of lipoproteins from and a of VLDL and and APOE4/4 of an that and APOE4/4 than VLDL and the of VLDL particles of lipoproteins from of and APOE4/4 from and of VLDL from and of a the the of VLDL to inhibit HDL activity be to of by of cell apoptosis by lipoproteins and that HDL cell HDL the lipoprotein apoptosis APOE of apoptosis by HDL from that the antiapoptotic activity of HDL that lipoproteins apoptosis the of of cell apoptosis by lipoproteins and that lipoproteins HDL antiapoptotic activity. that of apoptosis by total lipoproteins on APOE APOE4/4 lipoproteins apoptosis less than other APOE of APOE4/4 lipoproteins is to the ability of APOE4/4 VLDL to HDL activity by a mechanism requiring of apoE4 a LDL family receptor. of VLDL to inhibit HDL the that an family is the family VLDL to inhibit HDL antiapoptotic activity. of VLDL to inhibit HDL be by VLDL and APOE4/4 VLDL by an of VLDL APOE4/4 VLDL inhibited HDL activity. of is than that APOE4/4 VLDL the and E VLDL and the of VLDL the of VLDL to inhibit HDL HDL is the lipoprotein apoptosis APOE genotypes, including that from the of to the antiapoptotic effects of HDL the that HDL activity or HDL an LDL family that binding of VLDL to an LDL family inhibit the ability of HDL to cell binding of to an LDL family by HDL. the mechanism by which APOE4/4 VLDL HDL antiapoptotic activity is the of antiapoptotic activity of APOE4/4 lipoproteins be the APOE4 is a of including of the and of from to and of and and of the APOE4 is and of and of apolipoprotein E to effects and of apolipoprotein E and of apolipoprotein E and the of of the APOE4 be to the ability of APOE4 lipoproteins to inhibit apoptotic cell apoptosis and on and the and of of lipoprotein and sera and Moreover, the effects of the APOE on the and of lipoprotein of lipoprotein apolipoprotein lipoproteins of and of lipoproteins from of APOE E on to to apoptosis lipoproteins from the to be that of apoptosis by lipoproteins on APOE lipoproteins from the APOE4/4 apoptosis less than from other the antiapoptotic activity of HDL is by VLDL the apoE4 the APOE and be the Endothelial cells undergo apoptotic cell death to including growth and and of which to apoptosis and a of and cell apoptosis to and on and other as and inhibit cell apoptosis and of a apoptosis of cells from and the and to inhibit cell of cell apoptosis by lipoproteins and that HDL apoptosis cells by and that and antiapoptotic activity of HDL. of the family that the which of cell apoptosis by lipoproteins and and a apolipoprotein E lipoprotein and and is of from to and of and the the APOE4 of apoE4 and the LDL family of lipoprotein activity of the E to a the of lipoprotein and the of particles E and binding of lipoproteins to cell E VLDL and apoE4 HDL. and apoE4 VLDL and mechanism of lipoprotein of apolipoprotein on lipoprotein and of and and atherosclerosis, the E lipoprotein and of the LDL family of an of less than lipoprotein activity of the E to a HDL cell and the of APOE the of lipoprotein lipoproteins from sera of APOE inhibit and of cells from and and an of of cell and cells cells to and of of and or the of lipoproteins of lipoprotein of the and the of of sera as to 3/7 activity 3/7 activity measured the by a of is a to a a by and activity by the the of from that and caspase to activity the of lipoproteins to of lipoprotein APOE to or apoE4 apolipoprotein and of and and or APOE4 of the apolipoprotein E the and and from of on a from sera of as and of lipoproteins of by of and to by the of lipoproteins and lipoprotein of the of VLDL a of to a and HDL a and and total lipoproteins a of HDL to of the HDL particles the VLDL and to and a of lipoproteins and antiapoptotic activity of lipoproteins by antiapoptotic activity lipoproteins or on the total lipoproteins and lipoprotein and VLDL as the of the of lipoproteins sera of a APOE genotype. of the of sera to the of the lipoproteins from that sera the lipoprotein and by the of from the a of the lipoprotein to of to a of by the of of measured and the from to of lipoprotein from total lipoprotein to a to of that from and apolipoprotein E 4/4 (APOE4/4) a of lipoprotein to of to the by of cell apoptosis by lipoproteins and by on a an from to a of by and and of and to of the the the activity of ability to cells from apoptosis the caspase 3/7 activity and of of sera from on the lipoprotein to the by and by by by of by and enhanced to the and of cells from and and an of of cell and cells cells to and of of and or the of lipoproteins of lipoprotein of the and the of of sera cells from and and an of of cell and cells cells to and of of and or the of lipoproteins of lipoprotein of the and the of of sera as to as to 3/7 activity 3/7 activity measured the by a of is a to a a by and activity by the the of from that and caspase to activity the of lipoproteins to 3/7 activity measured the by a of is a to a a by and activity by the the of from that and caspase to activity the of lipoproteins to of lipoprotein APOE to or apoE4 apolipoprotein and of and and or APOE4 of the apolipoprotein E the and and from of on a from sera of as and of lipoproteins of by of and to by the of lipoproteins and lipoprotein of the of VLDL a of to a and HDL a and and total lipoproteins a of HDL to of the HDL particles the VLDL and to and a of lipoproteins and antiapoptotic activity of lipoproteins by antiapoptotic activity lipoproteins or on the total lipoproteins and lipoprotein and VLDL as the of the of lipoproteins sera of a APOE genotype. of the of sera to the of the lipoproteins from that sera the lipoprotein and by the of from the APOE to or apoE4 apolipoprotein and of and and or APOE4 of the apolipoprotein E the and and from of on a from sera of as and of lipoproteins of by of and to by the of lipoproteins and lipoprotein of the of VLDL a of to a and HDL a and and total lipoproteins a of HDL to of the HDL particles the VLDL and to and a of lipoproteins and antiapoptotic activity of lipoproteins by antiapoptotic activity lipoproteins or on the total lipoproteins and lipoprotein and VLDL as the of the of lipoproteins sera of a APOE genotype. of the of sera to the of the lipoproteins from that sera the lipoprotein and by the of from the a of the lipoprotein to of to a of by the of of measured and the from to a of the lipoprotein to of to a of by the of of measured and the from to of lipoprotein from total lipoprotein to a to of that from and apolipoprotein E 4/4 (APOE4/4) a of lipoprotein to of to the by of cell apoptosis by lipoproteins and by on a an from to a of by and and of and to of the the the activity of ability to cells from apoptosis the caspase 3/7 activity from total lipoprotein to a to of that from and apolipoprotein E 4/4 (APOE4/4) a of lipoprotein to of to the by of cell apoptosis by lipoproteins and by on a an from to a of by and and of and to of the the the activity of ability to cells from apoptosis the caspase 3/7 activity and of of sera from on the lipoprotein to the by and by by by of by and enhanced to the of sera from on the lipoprotein to the by and by by by of by and enhanced to the of apoptosis by total lipoproteins is APOE the APOE and by of and by lipoprotein and lipoproteins from from and from and or and the of lipoprotein APOE E and binding of lipoproteins to cell E VLDL and of the apolipoprotein E the and and from of lipoprotein APOE as the of lipoproteins the lipoproteins to the of caspase and lipoproteins from and sera apoptosis lipoproteins from APOE4/4 less apoptosis caspase activity of APOE4/4 and of sera to that of other and antiapoptotic activity APOE of cell apoptosis by lipoproteins and that the ability of lipoproteins to from apoptosis is by including and lipoproteins to of APOE4/4 lipoproteins the ability of lipoproteins to the of from the as the of the other to lipoprotein ability to from to the antiapoptotic activity of total lipoproteins from and APOE4/4 of antiapoptotic activity of total lipoproteins HDL antiapoptotic activity is on APOE the of total lipoproteins show a the APOE genotypes, the of lipoproteins and from and and and APOE4/4 sera ability to of the antiapoptotic activity the HDL APOE ability of HDL from to apoptosis that of apoptosis by HDL VLDL and lipoproteins from APOE a of the ability of HDL from APOE4/4 to inhibit apoptosis to that of HDL from other APOE the the of the lipoprotein genotypes, from or of lipoprotein on caspase activity of caspase activity by from and APOE4/4 than that or the HDL lipoproteins from APOE and APOE 4/4 sera inhibited caspase to a from the and as VLDL the antiapoptotic activity of VLDL from APOE the antiapoptotic activity of HDL. of of APOE4/4 VLDL to a of APOE4/4 HDL activity of HDL APOE4/4 or VLDL on HDL activity that the of apoptosis by the total lipoproteins APOE4/4 sera is to the ability of APOE4/4 VLDL to the antiapoptotic activity of HDL. the antiapoptotic activity of HDL is APOE of HDL activity. of of VLDL to a of HDL on HDL of caspase activity. VLDL from APOE4/4 from or inhibit the of caspase activity by HDL. as a APOE4/4 HDL and APOE4/4 HDL APOE4/4 other HDL or VLDL of other APOE HDL antiapoptotic VLDL HDL activity by a mechanism requiring the of the apoE4 on the which binding of to the LDL family of cell lipoprotein and including and an of on the ability of APOE4/4 VLDL to inhibit HDL. APOE4/4 VLDL from HDL antiapoptotic on the antiapoptotic activity of HDL that the effects of APOE4/4 VLDL binding of apoE4 to LDL family effects of on APOE4/4 VLDL of HDL activity. of HDL activity by APOE4/4 VLDL on VLDL from or to inhibit HDL activity from of the APOE as of VLDL to HDL activity be to the of of VLDL and the ability of to to the family can to HDL activity. VLDL to inhibit HDL antiapoptotic the LDL family VLDL of HDL activity from a of VLDL particles or a apoE4 the VLDL the the and APOE4/4 VLDL on the of VLDL APOE4/4 VLDL inhibited HDL the of VLDL which inhibit of APOE4/4 and of APOE4/4 and VLDL of HDL antiapoptotic activity on of VLDL the APOE4/4 VLDL lipoproteins show of HDL APOE4/4 and VLDL and a of and APOE4/4 to VLDL is as and VLDL from to on HDL activity of lipoproteins from and a of VLDL and and APOE4/4 of an that and APOE4/4 than VLDL and the of VLDL particles of lipoproteins from of and APOE4/4 from and of VLDL from and of a the the of VLDL to inhibit HDL activity be to of of apoptosis by total lipoproteins is APOE the APOE and by of and by lipoprotein and lipoproteins from from and from and or and the of lipoprotein APOE E and binding of lipoproteins to cell E VLDL and of the apolipoprotein E the and and from of lipoprotein APOE as the of lipoproteins the lipoproteins to the of caspase and lipoproteins from and sera apoptosis lipoproteins from APOE4/4 less apoptosis caspase activity of APOE4/4 and of sera to that of other the APOE and by of and by lipoprotein and lipoproteins from from and from and or and the of lipoprotein APOE E and binding of lipoproteins to cell E VLDL and of the apolipoprotein E the and and from of lipoprotein APOE as the of lipoproteins the lipoproteins to the of caspase and lipoproteins from and sera apoptosis lipoproteins from APOE4/4 less apoptosis caspase activity of APOE4/4 and of sera to that of other and antiapoptotic activity APOE of cell apoptosis by lipoproteins and that the ability of lipoproteins to from apoptosis is by including and lipoproteins to of APOE4/4 lipoproteins the ability of lipoproteins to the of from the as the of the other to lipoprotein ability to from to the antiapoptotic activity of total lipoproteins from and APOE4/4 of cell apoptosis by lipoproteins and that the ability of lipoproteins to from apoptosis is by including and lipoproteins to of APOE4/4 lipoproteins the ability of lipoproteins to the of from the as the of the other to lipoprotein ability to from to the antiapoptotic activity of total lipoproteins from and APOE4/4 of antiapoptotic activity of total lipoproteins HDL antiapoptotic activity is on APOE the of total lipoproteins show a the APOE genotypes, the of lipoproteins and from and and and APOE4/4 sera ability to of the antiapoptotic activity the HDL APOE ability of HDL from to apoptosis that of apoptosis by HDL VLDL and lipoproteins from APOE a of the ability of HDL from APOE4/4 to inhibit apoptosis to that of HDL from other APOE the the of the lipoprotein genotypes, from or the of total lipoproteins show a the APOE genotypes, the of lipoproteins and from and and and APOE4/4 sera ability to of the antiapoptotic activity the HDL APOE ability of HDL from to apoptosis that of apoptosis by HDL VLDL and lipoproteins from APOE a of the ability of HDL from APOE4/4 to inhibit apoptosis to that of HDL from other APOE the the of the lipoprotein genotypes, from or APOE4/4 VLDL the antiapoptotic activity of VLDL from APOE the antiapoptotic activity of HDL. of of APOE4/4 VLDL to a of APOE4/4 HDL activity of HDL APOE4/4 or VLDL on HDL activity that the of apoptosis by the total lipoproteins APOE4/4 sera is to the ability of APOE4/4 VLDL to the antiapoptotic activity of HDL. the antiapoptotic activity of HDL is APOE VLDL from APOE the antiapoptotic activity of HDL. of of APOE4/4 VLDL to a of APOE4/4 HDL activity of HDL APOE4/4 or VLDL on HDL activity that the of apoptosis by the total lipoproteins APOE4/4 sera is to the ability of APOE4/4 VLDL to the antiapoptotic activity of HDL. the antiapoptotic activity of HDL is APOE HDL antiapoptotic VLDL HDL activity by a mechanism requiring the of the apoE4 on the which binding of to the LDL family of cell lipoprotein and including and an of on the ability of APOE4/4 VLDL to inhibit HDL. APOE4/4 VLDL from HDL antiapoptotic on the antiapoptotic activity of HDL that the effects of APOE4/4 VLDL binding of apoE4 to LDL family APOE4/4 VLDL HDL activity by a mechanism requiring the of the apoE4 on the which binding of to the LDL family of cell lipoprotein and including and an of on the ability of APOE4/4 VLDL to inhibit HDL. APOE4/4 VLDL from HDL antiapoptotic on the antiapoptotic activity of HDL that the effects of APOE4/4 VLDL binding of apoE4 to LDL family of VLDL to HDL activity be to the of of VLDL and the ability of to to the family can to HDL activity. VLDL to inhibit HDL antiapoptotic the LDL family VLDL of HDL activity from a of VLDL particles or a apoE4 the VLDL the the and APOE4/4 VLDL on the of VLDL APOE4/4 VLDL inhibited HDL the of VLDL which inhibit the of VLDL particles of lipoproteins from of and APOE4/4 from and of VLDL from and of a the the of VLDL to inhibit HDL activity be to of of VLDL and the ability of to to the family can to HDL activity. VLDL to inhibit HDL antiapoptotic the LDL family VLDL of HDL activity from a of VLDL particles or a apoE4 the VLDL the the and APOE4/4 VLDL on the of VLDL APOE4/4 VLDL inhibited HDL the of VLDL which inhibit HDL. the of VLDL particles of lipoproteins from of and APOE4/4 from and of VLDL from and of a the the of VLDL to inhibit HDL activity be to of by of cell apoptosis by lipoproteins and that HDL cell HDL the lipoprotein apoptosis APOE of apoptosis by HDL from that the antiapoptotic activity of HDL that lipoproteins apoptosis the of of cell apoptosis by lipoproteins and that lipoproteins HDL antiapoptotic activity. that of apoptosis by total lipoproteins on APOE APOE4/4 lipoproteins apoptosis less than other APOE of APOE4/4 lipoproteins is to the ability of APOE4/4 VLDL to HDL activity by a mechanism requiring of apoE4 a LDL family receptor. of VLDL to inhibit HDL the that an family is the family VLDL to inhibit HDL antiapoptotic activity. of VLDL to inhibit HDL be by VLDL and APOE4/4 VLDL by an of VLDL APOE4/4 VLDL inhibited HDL activity. of is than that APOE4/4 VLDL the and E VLDL and the of VLDL the of VLDL to inhibit HDL HDL is the lipoprotein apoptosis APOE genotypes, including that from the of to the antiapoptotic effects of HDL the that HDL activity or HDL an LDL family that binding of VLDL to an LDL family inhibit the ability of HDL to cell binding of to an LDL family by HDL. the mechanism by which APOE4/4 VLDL HDL antiapoptotic activity is the of antiapoptotic activity of APOE4/4 lipoproteins be the APOE4 is a of including of the and of from to and of and and of the APOE4 is and of and of apolipoprotein E to effects and of apolipoprotein E and of apolipoprotein E and the of of the APOE4 be to the ability of APOE4 lipoproteins to inhibit apoptotic cell apoptosis and on and the and of of lipoprotein and sera and Moreover, the effects of the APOE on the and of lipoprotein of lipoprotein apolipoprotein lipoproteins of and of lipoproteins from of APOE E on to to apoptosis lipoproteins from the to be that of apoptosis by lipoproteins on APOE lipoproteins from the APOE4/4 apoptosis less than from other the antiapoptotic activity of HDL is by VLDL the apoE4 the APOE and be the by of cell apoptosis by lipoproteins and that HDL cell HDL the lipoprotein apoptosis APOE of apoptosis by HDL from that the antiapoptotic activity of HDL that lipoproteins apoptosis the of of cell apoptosis by lipoproteins and that lipoproteins HDL antiapoptotic activity. that of apoptosis by total lipoproteins on APOE APOE4/4 lipoproteins apoptosis less than other APOE of APOE4/4 lipoproteins is to the ability of APOE4/4 VLDL to HDL activity by a mechanism requiring of apoE4 a LDL family receptor. of VLDL to inhibit HDL the that an family is the family VLDL to inhibit HDL antiapoptotic activity. of VLDL to inhibit HDL be by VLDL and APOE4/4 VLDL by an of VLDL APOE4/4 VLDL inhibited HDL activity. of is than that APOE4/4 VLDL the and E VLDL and the of VLDL the of VLDL to inhibit HDL activity. HDL is the lipoprotein apoptosis APOE genotypes, including that from the of to the antiapoptotic effects of HDL the that HDL activity or HDL an LDL family receptor. that binding of VLDL to an LDL family inhibit the ability of HDL to cell binding of to an LDL family by HDL. the mechanism by which APOE4/4 VLDL HDL antiapoptotic activity is the of antiapoptotic activity of APOE4/4 lipoproteins be the APOE4 is a of including of the and of from to and of and and of the APOE4 is and of and of apolipoprotein E to effects and of apolipoprotein E and of apolipoprotein E and the of of the APOE4 be to the ability of APOE4 lipoproteins to inhibit apoptotic cell apoptosis and on and the and of of lipoprotein and sera and Moreover, the effects of the APOE on the and of lipoprotein of lipoprotein apolipoprotein lipoproteins of and of lipoproteins from of APOE E on to to apoptosis lipoproteins from the to be that of apoptosis by lipoproteins on APOE lipoproteins from the APOE4/4 apoptosis less than from other the antiapoptotic activity of HDL is by VLDL the apoE4 the APOE and be the This by the and the of

References

23